EffrosyniApostolidouMDPhD
Hematology • Houston, TXClotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder
Associate Professor, Consultant Hematologist, UT MD Anderson Cancer Center, Houston, TX
Dr. Apostolidou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Unit 1464
Houston, TX 77030
Summary
- Dr. Effrosyni Apostolidou is a Hematologist in the Section of Benign Hematology, at the MD Anderson Cancer Center, Houston, TX. Dr. Apostolidou received her medical degree from University of Athens and has been in practice 25 years. Her areas of expertise include clotting disorder, hematologic oncology, and hemophilia & bleeding disorder. Dr. Apostolidou has more than 45 publications and over 350 citings.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2016
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 2009 - 2012
University of AthensClass of 1993
University of Texas M.D. Anderson Cancer CenterClinical Research Fellowship
Certifications & Licensure
AZ State Medical License 2024 - 2026
TX State Medical License 2013 - 2026
WA State Medical License 2024 - 2026
GA State Medical License 2024 - 2025
MS State Medical License 2024 - 2025
OK State Medical License 2024 - 2025
TN State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsdel(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.Cheng Cameron Yin, Lynne V. Abruzzo, Xiaoyan Qiu, Effrosyni Apostolidou, Jorge E. Cortes
Cancer Genetics and Cytogenetics. 2009-07-01 - 1 citationsLuspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series.Shamis Khan, Sara Taveras Alam, Rosa Torres Ramos, John Etumbani Mbue, Effrosyni Apostolidou
Clinical Hematology International. 2022-12-01 - 10 citationsJAK2 inhibitors: A reality? A hope?Effrosyni Apostolidou, Hagop M. Kantarjian, Srdan Verstovsek
Clinical Lymphoma & Myeloma. 2009-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
